No serious health effects linked to mRNA COVID-19 vaccines
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
HIV prevention treatment shows gaps among key populations
A large, detailed look by Kaiser Permanente researchers at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.
5 Questions for . . . Ousseny Zerbo
Division of Research investigator Ousseny Zerbo, PhD, describes his long journey from his childhood and education in Burkina Faso to becoming an epidemiologist in Northern California.
New tool for early identification of COVID-19 surges
Health systems could use data from routine clinical care to identify the onset of upcoming COVID-19 surges as many as 6 weeks before they occur, Kaiser Permanente researchers found in a study published in the journal BMJ Open.
COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California
About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.
Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy
Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.
Kaiser Permanente Northern California deepens its COVID-19 research agenda
Researchers and clinicians with Kaiser Permanente Northern California are developing a wide-ranging research agenda to beat COVID-19, working at the accelerated pace demanded by a worldwide pandemic.
It’s flu season: What you need to know about the research
What does it take to be sure the annual flu vaccine is effective and safe? Research. In a podcast, Nicola Klein, head of the Vaccine Study Center, tackles some common questions about the vaccine and recent findings.
Active tuberculosis linked to higher long-term risk of death
People who recovered from active tuberculosis had a higher long-term risk of death from any cause than similar patients who never had active tuberculosis shows a new Kaiser Permanente study.
Study identifies geographic clusters of pregnant women who missed flu shots
A Kaiser Permanente analysis of women who did not get flu shots during their pregnancies found the women clustered in geographic “hot spots.” These women tended to have fewer prenatal medical visits and live in low-income neighborhoods.
